Confirming this possibility, WB analysis of proteins re-extracted from the DNase-treated RIPA pellet revealed strong RD3 immunoreactivity with PiD Tau and AD Tau, with only faint immunoreactivity with PSP and CBD Tau (Supp. This evidence concerns the gene RD3 and supranuclear palsy, progressive, 1.